Literature DB >> 26982034

Ischemia/reperfusion-induced lung injury prevention: many options, no choices.

Pedro Caruso1, Susimeire Gomes1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 26982034      PMCID： PMC4805380          DOI： 10.1590/S1806-37562016000100002

Source DB:  PubMed          Journal:  J Bras Pneumol        ISSN： 1806-3713            Impact factor:   2.624


× No keyword cloud information.
  7 in total

1.  The role of preconditioning and N-acetylcysteine on oxidative stress resulting from tourniquet-induced ischemia-reperfusion in arthroscopic knee surgery.

Authors:  Kenan Koca; Yuksel Yurttas; Tuncer Cayci; Serkan Bilgic; Umit Kaldirim; Murat Durusu; Yavuz Cekli; Huseyin Ozkan; Volkan Hanci; Vokan Hanci; Tarik Purtuloglu; Emin Ozgur Akgul; Erbil Oguz; Cemil Yildiz; Mustafa Basbozkurt
Journal:  J Trauma       Date:  2011-03

2.  A randomized controlled trial of pentoxifylline for the prevention of delayed graft function in cadaveric kidney graft.

Authors:  C Noël; M Hazzan; M C Coppin; M X Codaccioni; F R Pruvot; M Labalette; G Lelièvre
Journal:  Clin Transplant       Date:  1997-06       Impact factor: 2.863

3.  N-acetylcysteine does not prevent hepatorenal ischaemia-reperfusion injury in patients undergoing orthotopic liver transplantation.

Authors:  Ibtesam A Hilmi; Zhiyong Peng; Raymond M Planinsic; Daniela Damian; Feng Dai; Yulia Y Tyurina; Valerian E Kagan; John A Kellum
Journal:  Nephrol Dial Transplant       Date:  2010-02-22       Impact factor: 5.992

4.  Impact of high-dose N-acetylcysteine versus placebo on contrast-induced nephropathy and myocardial reperfusion injury in unselected patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. The LIPSIA-N-ACC (Prospective, Single-Blind, Placebo-Controlled, Randomized Leipzig Immediate PercutaneouS Coronary Intervention Acute Myocardial Infarction N-ACC) Trial.

Authors:  Holger Thiele; Lysann Hildebrand; Carmen Schirdewahn; Ingo Eitel; Volker Adams; Georg Fuernau; Sandra Erbs; Axel Linke; Klaus-Werner Diederich; Marek Nowak; Steffen Desch; Matthias Gutberlet; Gerhard Schuler
Journal:  J Am Coll Cardiol       Date:  2010-05-18       Impact factor: 24.094

5.  Effect of cyclosporine on reperfusion injury in acute myocardial infarction.

Authors:  Christophe Piot; Pierre Croisille; Patrick Staat; Hélène Thibault; Gilles Rioufol; Nathan Mewton; Rachid Elbelghiti; Thien Tri Cung; Eric Bonnefoy; Denis Angoulvant; Christophe Macia; Franck Raczka; Catherine Sportouch; Gerald Gahide; Gérard Finet; Xavier André-Fouët; Didier Revel; Gilbert Kirkorian; Jean-Pierre Monassier; Geneviève Derumeaux; Michel Ovize
Journal:  N Engl J Med       Date:  2008-07-31       Impact factor: 91.245

6.  Epidemiology and outcome of acute lung injury in European intensive care units. Results from the ALIVE study.

Authors:  Christian Brun-Buisson; Cosetta Minelli; Guido Bertolini; Luca Brazzi; Jorge Pimentel; Klaus Lewandowski; Julian Bion; Jacques-André Romand; Jesús Villar; Adalbjörn Thorsteinsson; Pierre Damas; Apostolos Armaganidis; François Lemaire
Journal:  Intensive Care Med       Date:  2003-10-16       Impact factor: 17.440

7.  Effects of N-acetylcysteine and pentoxifylline on remote lung injury in a rat model of hind-limb ischemia/reperfusion injury.

Authors:  Hamed Ashrafzadeh Takhtfooladi; Saeed Hesaraki; Foad Razmara; Mohammad Ashrafzadeh Takhtfooladi; Hadi Hajizadeh
Journal:  J Bras Pneumol       Date:  2016 Jan-Feb       Impact factor: 2.624
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.